Companies: 49,246 Total Market Cap: 132578865767700.31

HAEMATO AG

HAM-HAEK

Drugs, Drug Proprietaries, and Druggists' Sundries

Rank #26286

Market Cap 73.72 M

Volume 66

Price 13.76

Change (%) 0.81%

Country or region

Germany

HAEMATO AG's latest marketcap:

73.72 M

As of 05/20/2025, HAEMATO AG's market capitalization has reached $73.72 M. According to our data, HAEMATO AG is the 26286th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	73.72 M
Revenue (ttm)	294.22 M
Net Income (ttm)	10.84 M
Shares Out	5.23 M
EPS (ttm)	2.12
Forward PE	0.00
Ex-Dividend Date	07/17/2024
Earnings Date	n/a

Market Cap Chart

Data Updated: 05/20/2025

HAEMATO AG's yearly market capitalization.

HAEMATO AG has seen its market value drop from €119.19 M to €65.34 M since 2021, representing a total decrease of 45.18% and an annual compound decline rate (CAGR) of 15.90%.

Date	Market Cap	Change (%)
05/20/2025	€65.34 M	-0.81%
12/30/2024	€64.82 M	-40.95%
06/28/2022	€109.78 M	-7.89%
11/30/2021	€119.19 M

Company Profile

About HAEMATO AG

HAEMATO AG, along with its subsidiaries, is a key player in the German pharmaceutical sector. The company focuses on the development, acquisition, licensing, and distribution of a diverse range of healthcare products.

Business Segments

Specialty Pharma: Provides prescription drugs and OTC products, specializing in HIV/AIDS, neurology, oncology, and rheumatology.
Lifestyle & Aesthetics: Offers special cosmetics and dietary supplements under brands like M1 SELECT.

Product Portfolio

Pharmaceuticals for chronic and specialized treatments.
Diagnostic tests under the HAEMATO brand.
Third-party product distribution.

Customer Base

HAEMATO AG serves a wide network of clients, including:

Clinics
Pharmacies
Wholesalers
Medical test centers

Company Background

Founded in 1993, HAEMATO AG is headquartered in Schönefeld, Germany.

Frequently Asked Questions

As of 05/20/2025, HAEMATO AG (including the parent company, if applicable) has an estimated market capitalization of $73.72 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

HAEMATO AG global market capitalization ranking is approximately 26286 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Germany
Founded	1993
IPO Date	n/a
Employees	76
CEO
Sector
Industry	Drugs, Drug Proprietaries, and Druggists' Sundries
Address	Lilienthalstrasse 3a Schönefeld, 12529 Germany
Website	https://www.haemato.ag